Management of infections caused by vancomycin-resistant gram-positive bacteria.

نویسندگان

  • Bindiya Bagga
  • Jerry L Shenep
چکیده

For 3 decades, vancomycin has been a favored therapy for serious penicillinand cephalosporin-resistant Gram-positive bacterial infections. Development of vancomycin resistance may have been restrained by the requirement for intravenous administration, which limited its use and lessened exposure to the gastrointestinal flora. Nevertheless, physicians are increasingly encountering children and adults infected with vancomycin-resistant Gram-positive organisms. Resistance to vancomycin has been encountered in all commonly occurring, clinically significant Gram-positive bacterial species except Streptococcus pyogenes, Streptococcus pneumoniae, and Streptococcus agalactiae. Although therapeutic options are usually guided by the antimicrobial susceptibilities of individual isolates, recommended infection-control measures vary with the specific species and the mechanism of resistance. VANCOMYCIN-RESISTANT STAPHYLOCOCCUS AUREUS Vancomycin-resistant Staphylococcus aureus (VRSA) were first recognized in Japan in 1996; the first case of infection due to VRSA in the United States was reported in 2002. Since then, at least 8 additional cases of VRSA infection have been identified in the United States, with more than half of these cases occurring in Michigan. Isolates often seem to have evolved independently in settings where patients were previously colonized with vancomycin-resistant enterococcus (VRE) and methicillin-resistant S. aureus (MRSA). Environments that promote biofilm formation may facilitate transmission of resistance from VRE to MRSA. VRSA isolates (vancomycin MIC 16 g/mL) are fundamentally different from vancomycin-intermediate S. aureus (VISA) isolates (vancomycin MIC 4 – 8 g/mL). Resistance in VISA isolates is typically mediated via mechanisms that develop in the presence of vancomycin and are not readily transferrable to other strains. The potential for spread of these isolates is low in the absence of vancomycin therapy. In contrast, VRSA isolates uniformly contain the vanA gene derived from enterococcus (discussed below). The VanA phenotype is transferable to other MRSA strains and across microbial species, with a much greater potential for spread, even in the absence of vancomycin therapy. Thus far, VRSA outbreaks have not occurred; however, because of the potential for spread with dire consequences, a case of VRSA infection warrants a more rigorous infection-control response than a case of infection with MRSA, VISA, or VRE. Infection-control measures should be implemented urgently according to a written plan, if VRSA is suspected. The local health department and the Centers for Disease Control and Prevention should be consulted immediately. Management of contacts should occur according to contact categorization. Attempts to decolonize individuals who are found to be colonized should be considered on a case-by-case basis. Infections with S. aureus isolates that have vancomycin MICs 4 g/mL typically do not respond clinically to vancomycin therapy. To date, all VRSA have also been found to be resistant to methicillin. Fortunately, all VRSA and VISA isolates have been susceptible to one or more commercially available antibiotics. Recommended antibiotics for VRSA and VISA, according to susceptibilities and other clinical considerations, are listed in Table 1. Secondary agents include teicoplanin (not available in the United States), trimethoprim-sulfamethoxazole, tetracycline, rifampin (usually in combination therapy), and chloramphenicol.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

Telavancin is a novel antibiotic being investigated for the treatment of serious infections caused by Gram-positive bacteria, including complicated skin and skin structure infections (cSSSI) and pneumonia. This once-daily intravenous lipoglycopeptide exerts rapid bactericidal activity via a dual mechanism of action. It is intended for use to combat infections caused by Staphylococcus aureus and...

متن کامل

Quinupristin-dalfopristin: a new antibiotic for severe gram-positive infections.

The steady increase in resistant organisms is related to the widespread use of antibiotics in community and hospital settings. New therapeutic options are needed, including treatments for infections caused by antibiotic-resistant gram-positive organisms. Quinupristin-dalfopristin, the first formulation of a distinct class of antibiotics known as the streptogramins, has activity against a range ...

متن کامل

Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.

BACKGROUND Rising rates of multi-drug-resistant, gram-positive cocci (e.g., methicillin-resistant Staphylococcus aureus [MRSA], vancomycin-resistant Enterococcus spp. [VRE]) have created treatment challenges for clinicians in both the hospital and community settings. These organisms have become especially problematic for hospitalized patients with pneumonia, complicated intra-abdominal infectio...

متن کامل

Determination of the Resistance Pattern of Prevalent Aerobic Bacterial Infections of Diabetic Foot Ulcer

Background and Objective: Diabetes mellitus is one of the main problems in health systems in the world. Diabetic Foot infections (DFI) is one of the main complications and the most cause  of non-traumatic lower limb amputation .This study aimed to determine the prevalence of bacteria involved in DFI and their antibiotic resistance in patients with DFI diagnosis. Patients and Metho...

متن کامل

بررسی فراوانی انتروکوک و استافیلوکوک‌های مقاوم به ونکومایسین جدا شده از عفونت‌های ادراری

Background: The role of gram-positive cocci especially Staphylococci species in causing urinary tract infection are well known. Among the Staphylococci species Methicillin Resistance Staphylococcus aureus (MRSA) is the most important. The rate of MRSA is increasing worldwide. This is alarming because the danger of these organism in public health. Therefore the aim of this study was to determine...

متن کامل

Emergence of Vancomycin-Resistant Staphylococcus Aureus (VRSA)

Background: Staphylococcus aureus is one of the bacteria under the genus Staphylococcus which is a gram-positive coccus. It is microscopically observed as individual organisms, in pairs and in irregular, grapelike clusters. S. aureus is non-motile and non-spore forming bacteria. It is one of the most common community and nosocomial pathogen. It mainly causes skin and soft tissue infections as i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Pediatric infectious disease journal

دوره 29 7  شماره 

صفحات  -

تاریخ انتشار 2010